LORIS AI predicts patient outcomes with immune checkpoint blockade therapy

[cesanon]

Sort of important because immune checkpoint blockade therapy apparently has a lower success rate that bat bipolar androgen therapy.

LORIS robustly predicts patient outcomes with immune checkpoint blockade therapy using common clinical, pathologic and genomic features | Nature Cancer

Https://nature.com/articles/s43018-...

The details:

In a new study, researchers showed how they can accurately predict whether immunotherapy drugs will work for a particular patient.

That treatment uses immune cells — the ones our bodies use to fight infections and other illnesses — to kill off cancer cells.

On average, it only works for around 20% of patients, depending on cancer type and other factors, but it can be life-saving in cases where it’s effective.